SCTL
Get informed when a big investor buys or sells
+ Follow| Market cap | $116.13 Million |
|---|---|
| Enterprise Value | $146.78 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.14 |
| Beta | 1.58 |
| Outstanding Shares | 104,856,247 |
| P/E Ratio | -7.89 |
|---|---|
| PEG | 8.63 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 1.55 |
| Enterprise Value to EBIT | -37.41 |
| Enterprise Value to Net Income | -12 |
| Total Debt to Enterprise | 0.26 |
| Debt to Equity | 0.66 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
Recro Pharma Inc. is a contract development and manufacturing organization (CDMO) with capabilities from early feasibility to commercial manufacturing. With an expertise in solving complex manufacturing problems, Recro is a leading CDMO ...